Erin Watson

Erin Watson

Auto-generated profile, based on publicly available information

Erin Watson

University of Saskatchewan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SPShelley Peacock
Shelley Peacock
SKStephanie Konrad
Stephanie Konrad
EWErin Watson
Erin Watson
DNDarren Nickel
Darren Nickel
NMNazeem Muhajarine
Nazeem Muhajarine
The effectiveness of paraprofessional home-visitations on improving the circumstances of disadvantaged families is unclear. The purpose of this paper is to systematically review the effectiveness of paraprofessional home-visiting programs on developmental and health outcomes of young children from disadvantaged families.

1 March 2014 in Value in Health
Verified
Journal Article
Closed access
MAM.H.D. Wasem Alsabbagh
M.H.D. Wasem Alsabbagh
MLMark Lemstra
Mark Lemstra
DEDean Eurich
Dean Eurich
LLLisa M. Lix
Lisa M. Lix
TWThomas W. Wilson
Thomas W. Wilson
DBDavid F. Blackburn
David F. Blackburn

1 July 2017 in The Journal of Academic Librarianship
Verified
Journal Article
Closed access
LZLi Zhang
Li Zhang
EWErin M. Watson
Erin M. Watson

1 July 2007 in The Journal of Academic Librarianship
Verified
Journal Article
Closed access
LZLi Zhang
Li Zhang
EWErin M. Watson
Erin M. Watson
LBLaura Banfield
Laura Banfield

10 May 2011 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
CECharity D Evans
Charity D Evans
EWErin Watson
Erin Watson
DEDean T Eurich
Dean T Eurich
JTJeff G Taylor
Jeff G Taylor
EYErin M Yakiwchuk
Erin M Yakiwchuk
DBDavid Blackburn
David Blackburn
Objective: To systematically review and assess the quality of studies evaluating community pharmacist interventions for preventing or managing diabetes or cardiovascular disease (CVD) and/or their major risk factors. Data Sources: A comprehensive literature search was performed using MEDLINE (1950-February 2011), EMBASE (1980-February 2011), International Pharmaceutical Abstracts (1970-February 2011), Cumulative Index to Nursing and Allied Health Literature (1982-June 2007), and Cochrane Central Register of Controlled Trials (1898-February 2011). Search terms included: community pharmacy(ies), community pharmacist(s), cardiovascular, diabetes, and intervention. The grey literature was searched using the ProQuest Dissertations and Theses, Theses Canada, and OAlster databases. Study Selection and Data Extraction: Articles published in English or French with all study designs were considered for the review. Studies were included if they contained interventions designed to reduce the incidence, risk, or mortality of CVD or diabetes; affect clinical indicators of CVD or diabetes mellitus (including hypertension, dyslipidemia, or hemoglobin A 1c ); and/or improve adherence to treatment strategies. Only studies involving interventions carried out primarily by pharmacists in community pharmacy settings were included. Study quality was assessed using a checklist validated for both randomized and nonrandomized studies. Data Synthesis: A total of 4142 studies were initially identified, with 40 meeting our inclusion criteria. Eleven studies were randomized controlled trials, 4 were cluster randomized trials, and 2 studies had randomized before-after designs. The remaining studies were controlled before-after (n = 2), cohort (n = 4), and uncontrolled before-after (n = 17) designs. Interventions focused on diabetes (n = 12), hypertension (n = 9), medication adherence (n = 9), lipids (n = 5), evidence-based medication initiation or optimization (n = 3), risk factor prediction scores (n = 1), and body mass index (n = 1). All studies contained interventions focused at the patient level and the majority of studies (34/40) involved interventions directed at both the physician and patient. No specific intervention emerged as superior, and study quality was generally poor, making it difficult to determine the true effect of the interventions. Conclusions: Poor study quality, time-intensive interventions, and unproven clinical significance warrant the need for further high-quality studies of community pharmacist interventions for preventing or managing diabetes or CVD and/or their major risk factors.

3 July 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
DGDonna Goodridge
Donna Goodridge
MMMeghan McDonald
Meghan McDonald
LNLucia New
Lucia New
MSMurray Scharf
Murray Scharf
EHElizabeth Harrison
Elizabeth Harrison
EPErika D Penz
Erika D Penz
Objectives To map the existing literature and describe interventions aimed at building the capacity of patients to participate in care during hospitalisation by: (1) describing and categorising the aspects of care targeted by these interventions and (2) identifying the behaviour change techniques (BCTs) used in these interventions. A patient representative participated in all aspects of this project. Design Scoping review. Data sources MEDLINE, Embase and CINAHL (Inception −2017). Study selection Studies reporting primary research studies on building the capacity of hospitalised adult patients to participate in care which described or included one or more structured or systematic interventions and described the outcomes for at least the key stakeholder group were included. Data extraction Title and abstract screening and full text screening were conducted by pairs of trained reviewers. One reviewer extracted data, which were verified by a second reviewer. Interventions were classified according to seven aspects of care relevant to hospital settings. BCTs identified in the articles were assigned through consensus of three reviewers. Results Database searches yielded a total 9899 articles, resulting in 87 articles that met the inclusion criteria. Interventions directed at building patient capacity to participate in care while hospitalised were categorised as those related to improving: patient safety (20.9%); care coordination (5.7%); effective treatment (5.7%) and/or patient-centred care using: bedside nursing handovers (5.7%); communication (29.1%); care planning (14%) or the care environment (19.8%). The majority of studies reported one or more positive outcomes from the defined intervention. Adding new elements (objects) to the environment and restructuring the social and/or physical environment were the most frequently identified BCTs. Conclusions The majority of studies to build capacity for participation in care report one or more positive outcomes, although a more comprehensive analysis is warranted.